The Battle for Continuous Glucose Monitoring Insurance Coverage
Recurring Medicare denials a mystery
By Joe Guarneri
dLife Staff Writer
David Terleckas, a 57-year-old resident of Pennsylvania, has had type 1 diabetes for nearly 47 years. On top of this, he is hypoglycemic unaware, making coping with his diabetes that much more of a challenge. In the past, David had always used a continuous glucose monitor to combat this condition and avoid having to constantly check his blood glucose level – until recently. Being forced to retire early due to diabetes, he is now covered under Medicare, who is currently denying coverage of CGMs and other related diabetes supplies. With the severe risks that diabetes poses and the convenience CGMs bring to those who attempt to combat it daily, why is continuous glucose monitoring insurance coverage by Medicare so difficult to obtain?
There are close to 100,000 hypoglycemia-related Emergency Room visits a year, with 29% resulting in hospitalization. If you add the possibility of hypoglycemic unawareness in some of those cases, the severity of the situation rises and the increased chance for self-injury and harm to others becomes even more striking. David emphasized the fact that when a person's blood sugar reaches a harmful low, it becomes hard for them to control their actions. "You can't seem to get this across to Medicare," David said.
In an attempt to get through to Medicare, David (pictured left), along with his wife, a close neighbor, and his doctor, appeared before a judge in order to try to sway Medicare toward covering his CGM. "The case ended up being in our favor, but when I reordered the CGM, it was denied again." So despite all of this, David would have to appeal every time he ordered supplies for his CGM, something that anyone with diabetes knows occurs very frequently. Along with the hearing, David even spoke to representatives in the Surgeon General's office, as well as Medicare representatives in Washington, D.C.
In response to this issue in general, Claudia Graham, the Vice President of Global Access at Dexcom, has been working among a coalition of patient advocates, clinical societies, and companies "focused on the goal of providing access to CGM for Medicare beneficiaries, as it is nearly universally available in the commercial market." She explains that in order for Medicare to cover a given product, it must be assigned to a benefit category. "This is exactly where the hang up is," Claudia says. "Medicare is saying that CGM devices, according to their FDA label, must rely on self monitoring of blood glucose prior to making dosage/treatment decisions, and because of this Medicare will not assign a ‘benefit category'." Claudia and the rest of those involved are trying to voice to Medicare the value of CGMs to those who need them. She feels that because the device has allowed so many people to avoid hypoglycemic events, the fact that those same people are being denied coverage on it upon turning 65 is unfathomable. When asked why continuous glucose monitoring insurance coverage is being denied, Medicare replied that denial is purely based on the medical information submitted on one's claim.
While people like David and Claudia continue to express the importance of CGM to Medicare, it is important to know what to do if you find yourself in a similar situation. David advises others in his position to pursue it – go through the necessary appeals, and research to find people who can help in the process. He also stresses the importance of communicating with your doctor, as they can help you find other options, as well as aid you in communicating with Medicare and other organizations. By taking part in all of this, you can not only help yourself, but also help the rest of those making the effort to get through to Medicare on this serious issue.
One in Ten AMI Patients Have Unrecognized Incident Diabetes
Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease
COBA Conference Steers Forward in the Fight Against Childhood Obesity
Google Secures Patent for Glucose-Sensing Contact Lens
Medtronic to Use GlucoSitter Artificial Pancreas Software in Future Insulin Pumps - A Big Deal!
Arugula and Radish Salad Chocolate-Dipped Orange Logs Raspberry Dream Mousse Egg Drop and Asparagus Soup Raspberry Cheese Spread Salmon Spread Grilled Three-Cheese Cucumber Sandwich Sausage Hash Brown Frittata Raspberry Smoothie Grilled Chicken with Mango Salsa
My diabetes is changing. Until a few years ago, my morning readings were reasonable and within the desired range of under 100 mg/dl. About two years ago, they started slipping upwards into the less-desirable but apparently not-worrisome range of 100-110 mg/dl. Now, this was what was recorded by my Abbott Freestyle Lite meter, which is known to record at the lower end of the home-glucometer variability range, but with my A1c firmly in the high 5s and low 6s, the meter's tendency to...